Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Treatment for gum disease to slow heart valve narrowing

Official title: Intensive Treatment on Periodontitis in Aortic Stenosis

Run by China National Center for Cardiovascular Diseases · NCT06587971 · Data updated 2026-11-12

This study is testing if treating gum disease can help slow down the worsening of heart valve narrowing in adults who have both aortic valve stenosis and gum issues.

More Periodontitis trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment920 (estimated)
SponsorChina National Center for Cardiovascular Diseases
Government
Locations1 site (Beijing, Beijing Municipality)
StatusRecruiting
StartedMay 10, 2023
Main results expectedDecember 31, 2025
Study endsDecember 2027
Registry record updatedSeptember 19, 2024
Trial IDNCT06587971 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 years or older with moderate aortic valve stenosis and mild-to-moderate periodontitis.

Probably not a fit

Patients with end-stage renal disease, those who are pregnant or breastfeeding, or individuals unable to adhere to the treatment protocol may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to determine whether standardized periodontal therapy can slow the progression of aortic valve stenosis in adults with moderate aortic valve stenosis and coexisting gingivitis or mild-to-moderate periodontitis. Participants will be screened for eligibility based on their aortic valve peak velocity and periodontal status, and then randomly assigned to either receive comprehensive periodontal therapy or only oral hygiene education. The study seeks to answer if chronic periodontitis is an independent risk factor for the accelerated progression of aortic valve stenosis.

Why it matters

Potential benefit: If successful, this treatment could potentially slow the progression of aortic valve stenosis in patients with periodontal disease.

How similar studies have gone: There is limited information on similar studies, making this approach relatively novel and untested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Aged 18 years or older.
* Aortic valve peak velocity (Vmax) between 3.0 and 3.9 m/s.
* Diagnosis of aortic valve stenosis identified as degenerative aortic valve stenosis.
* Presence of gingivitis or mild-to-moderate periodontitis confirmed by periodontal probing or panoramic dental radiography.
* Willingness to participate in the study and signing of informed consent.

Exclusion Criteria:

* End-stage renal disease with eGFR \< 15 ml/min/1.73m² (according to the Cockcroft \& Gault formula).
* Pregnant, breastfeeding, and women of childbearing age (except those with effective contraception).
* Factors that may affect study follow-up or adherence to periodontal therapy.
* Patients unwilling or unable to undergo comprehensive periodontal treatment.
* Patients who do not consent to participate in the study.

Where it's running

  • China National Center for Cardiovascular Diseases
    Beijing, Beijing Municipality, China
    Recruiting

Study contacts

  • Principal investigator: Erli Zhang, MD, PhD — China National Center for Cardiovascular Diseases
  • Study coordinator: Erli Zhang, MD, PhD
  • Email: aricho1985@163.com
  • Phone: +86-18500853301

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.